GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DNA Chip Research Inc (TSE:2397) » Definitions » Debt-to-Asset

DNA Chip Research (TSE:2397) Debt-to-Asset : 0.00 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is DNA Chip Research Debt-to-Asset?

DNA Chip Research's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.0 Mil. DNA Chip Research's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0.0 Mil. DNA Chip Research's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was 円966.7 Mil. DNA Chip Research's debt to asset for the quarter that ended in Sep. 2024 was 0.00.


DNA Chip Research Debt-to-Asset Historical Data

The historical data trend for DNA Chip Research's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Chip Research Debt-to-Asset Chart

DNA Chip Research Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DNA Chip Research Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of DNA Chip Research's Debt-to-Asset

For the Diagnostics & Research subindustry, DNA Chip Research's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DNA Chip Research's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DNA Chip Research's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DNA Chip Research's Debt-to-Asset falls into.



DNA Chip Research Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DNA Chip Research's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

DNA Chip Research's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DNA Chip Research  (TSE:2397) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


DNA Chip Research Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of DNA Chip Research's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Chip Research Business Description

Traded in Other Exchanges
N/A
Address
1-1-43 Suehirocho, Tsurumi-ku, Yokohama, JPN
DNA Chip Research Inc is specializing in the development of DNA microarrays. Its major business is focused on research and development, contract research service, and diagnostic support service. The company provides a wide variety of analytical services, from DNA chips to state-of-the-art next-generation sequencing. In addition, it provides consultation on experimental planning, sample preparation, statistical analysis, and manuscript preparation, catering to researchers' needs and requirements.

DNA Chip Research Headlines

No Headlines